Peripheral Arterial Disease (PAD) Treatment Devices

Boston Scientific Corp. CE mark Ranger Ranger Paclitaxel-coated PTA Balloon Cath

Boston Scientific received CE mark for the Ranger Paclitaxel-coated PTA Balloon Catheter. The technology is now in full European market launch. 

May 16, 2014 — In a move to expand significantly its portfolio of solutions for peripheral interventions, Boston Scientific Corp. has entered into a definitive agreement to acquire the interventional division of Bayer AG for $415 million...

The U.S. Food and Drug Administration (FDA) approved Abbott’s Supera Peripheral Stent System to treat people with blocked blood vessels in the upper leg caused by peripheral artery disease (PAD).

The U.S. Food and Drug Administration (FDA) cleared Cardiovascular Systems Inc.’s Diamondback 360 60 cm Peripheral Orbital Atherectomy Systems (OAS) for the treatment of peripheral arterial disease (PAD).

Biotronik BIOLUX 4Ever Clinical Trial Pulsar-18 SES Passeo-18 Lux DRB PAD Cath
Biotronik announced that the first patient has been enrolled in the investigator-initiated BIOLUX 4EVER trial. 
Boston Scientific Corp. CE mark Ranger Ranger Paclitaxel-coated PTA Balloon Cath
Boston Scientific received CE mark for the Ranger Paclitaxel-coated PTA Balloon Catheter. The technology is now in full European market launch. 
A new series of expert consensus recommendations developed by the Society for Cardiovascular Angiography and Interventions (SCAI) will help physicians...
July 18, 2014 — Avinger announced that John Pigott, M.D., of Jobst Vascular Institute, Toledo, Ohio, enrolled the first patient in the VISION trial, a global...
Cordis Corp.'s Saber PTA (percutaneous transluminal angioplasty) dilatation catheter is for the treatment of patients with peripheral
Cardiovascular Systems Inc.’s Diamondback 360 60 cm Peripheral Orbital Atherectomy Systems (OAS) are for the treatment of peripheral...
Boston Scientific's OffRoad Re-Entry Catheter System treats complete arterial blockages in the major arteries of the legs. ...
AtheroMed's Phoenix Atherectomy System. This system allows physicians to treat peripheral artery disease (PAD) with a low...

Articles

Boston Scientific Corp. CE mark Ranger Ranger Paclitaxel-coated PTA Balloon Cath
Boston Scientific received CE mark for the Ranger Paclitaxel-coated PTA Balloon Catheter. The technology is now in full European market launch. 
FDA Recommendation Lutonix Drug Coated Balloon Catheter
C. R. Bard Inc. announced that the U.S. Food and Drug Administration’s (FDA) Circulatory System Devices Advisory Panel provided a unanimous favorable...
New appropriate use expert consensus documents developed by the Society for Cardiovascular Angiography and Interventions (SCAI) provide guidance on treating...
Medtronic announced it is purchasing Covidien in a cash-and-stock deal for $42.9 billion. Once the transaction is completed, Medtronic will have significantly...

Video Center

The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
6 days 10 hours ago
A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost...
3 weeks 1 day ago
There were several new cardiovascular ultrasound technology advances highlighted at the American...
4 weeks 9 hours ago
Join Ascendian Healthcare Consulting and GE Healthcare during a webinar Wednesday, July 16 to learn about the access, productivity, and revenue cycle...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...
Centricity Cardio Enterprise, Cardiac PACS, Cardio PACS, CVIS
February is American Heart Month, the perfect time to evaluate the health of your cardiology IT system. 
Join us Feb. 25, 2-3 p.m. Eastern for a live...

Comparison Charts

Sorry there is no data available